<DOC>
	<DOCNO>NCT02374931</DOCNO>
	<brief_summary>This pilot clinical trial study fluorine ( F ) -18 16 alpha-fluoroestradiol ( 18F-FES ) positron emission tomography ( PET ) /computed tomography ( CT ) image patient desmoid tumor . 18F-FES bind estrogen receptor , present desmoid tumor , give radiation may detect PET CT scan . The PET/CT scan form image may show tumor cell estrogen receptor find body .</brief_summary>
	<brief_title>18F-FES PET/CT Imaging Patients With Desmoid Tumors</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Establish avidity desmoid tumor 18F-FES PET/CT imaging . II . Correlate 18F-FES PET avidity degree estrogen receptor ( ER ) expression immunohistochemistry ( IHC ) . OUTLINE : Patients undergo 18F-FES PET/CT image 30 minute . After completion study , patient follow 30 day .</detailed_description>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Fibromatosis , Aggressive</mesh_term>
	<mesh_term>Fibroma</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Patients biopsyproven extraabdominal desmoid tumor Not currently estrogen medication birth control , menopause , reason No antiestrogen therapy desmoid tumor within past 6 month Both sporadic desmoid tumor associate familial adenomatous polyposis ( FAP ) syndromes included Pregnancy nursing patient Patients wish participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>desmoid</keyword>
	<keyword>FES-PET</keyword>
	<keyword>aggressive fibromatosis</keyword>
</DOC>